GE HealthCare

GE HealthCare is a global healthcare solutions company that designs and supplies medical technology, intelligent devices, AI-powered software and care delivery innovations. Its operations are organised into four segments: Imaging, which pairs imaging hardware with more than 200 imaging software applications for clinicians; Ultrasound, covering ultrasound imaging systems for clinical diagnostics; Patient Care Solutions, covering monitoring, life support and care delivery equipment aimed at improving hospital efficiency and clinical outcomes; and Pharmaceutical Diagnostics, which produces diagnostic imaging agents and related pharmaceutical solutions.

The company traces its origins to 1892 and became an independent public company on January 4th 2023, when it was spun off from General Electric and listed on Nasdaq. It employs approximately 54,000 people and serves customers in more than 160 countries, from major medical centres worldwide to remote regions such as Greenland. Annual revenue stands at $20.6 billion, and its equipment is used to serve more than one billion patients a year, with an installed base of more than five million units.

Engineering and research are central to the business. The company invests more than $5.1 billion annually in R&D and product development and holds more than 11,000 granted patents globally. Technical domains span medical imaging, ultrasound technology, patient care monitoring and life support, pharmaceutical diagnostics, AI-powered clinical software, medical device engineering and precision care analytics. Across more than 130 years of operation, the stated purpose has been to create a world where healthcare has no limits, with a focus on personalised, precise patient care and on partnerships with customers.